Integrated Biopharma (INBP) Common Equity (2011 - 2026)
Integrated Biopharma (INBP) reported Common Equity of $17.67 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 13.0% from $20.32 million a year earlier and down 6.9% from the prior quarter.
Powered by 
Analysis
Integrated Biopharma (INBP) Common Equity (2011 - 2026) Analysis & Trends
Dating back to fiscal Q4 2011, Integrated Biopharma's Common Equity record includes 59 quarters.
- Common Equity has a five-year compound annual growth rate of 4.3% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $20.32 million in FY2025 (+5.6%), $19.24 million in FY2024 (+2.0%), $18.86 million in FY2023 (+1.5%) and $18.58 million in FY2022 (+29.6%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Common Equity since fiscal Q2 2025.
- Year over year, Common Equity gained in three of the last seven quarters, with an average decline of 14.0%.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2022 (growth of 109.3%); the low point was fiscal Q2 2025 (a decline of 99.9%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $18.98 million (Q3 2026), $19.77 million (Q2 2026) and $20.49 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn | 54.31 Bn |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn | 566.00 Mn |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn | 3.81 Bn |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn | 10.55 Bn |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn | 1.87 Bn |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn | 4.35 Bn |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn | 252.00 Mn |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn | 1.17 Bn |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn | 2.31 Bn |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 | 17.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.67 Mn |
| Mar 31, 2026 | 18.98 Mn |
| Dec 31, 2025 | 19.77 Mn |
| Sep 30, 2025 | 20.49 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | 20.38 Mn |
| Dec 31, 2024 | 19,727.00 |
| Sep 30, 2024 | 18.55 Mn |
| Jun 30, 2024 | 19.24 Mn |
| Mar 31, 2024 | 18.91 Mn |
| Dec 31, 2023 | 18.57 Mn |
| Sep 30, 2023 | 18.89 Mn |
| Jun 30, 2023 | 18.86 Mn |
| Mar 31, 2023 | 18,741.00 |
| Dec 31, 2022 | 18.65 Mn |
| Sep 30, 2022 | 18.62 Mn |
| Jun 30, 2022 | 18.58 Mn |
| Mar 31, 2022 | 16.98 Mn |
| Dec 31, 2021 | 16.07 Mn |
| Sep 30, 2021 | 14.89 Mn |
API Access
Integrated Biopharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();